Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Manufacturing symbols : Nrxp save search
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
Published: 2024-04-17 (Crawled : 21:00) - prnewswire.com
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: -27.51%
H: 7.59%
C: -0.33%
offering
NRx Pharmaceuticals, Inc. Announces New Data on NRX-101
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: -0.93%
H: 0.94%
C: -1.88%
nrx-101
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 1.17%
H: 0.29%
C: -5.41%
htx-100 pharmaceuticals
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
Published: 2024-04-08 (Crawled : 12:30) - prnewswire.com
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 0.57%
H: 7.01%
C: 3.79%
nrx-101 depression treatment pharmaceuticals trial
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 895.97%
H: 14.34%
C: 11.7%
business year update pharmaceuticals financial results
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights
Published: 2024-03-28 (Crawled : 12:00) - prnewswire.com
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: -9.43%
H: 12.5%
C: -1.69%
year pharmaceuticals financial results
UPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
Published: 2024-03-26 (Crawled : 20:00) - prnewswire.com
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 2.58%
H: 3.89%
C: 0.13%
report year pharmaceuticals financial results
NRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UK
Published: 2024-03-25 (Crawled : 12:30) - prnewswire.com
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: -1.95%
H: 5.63%
C: -3.48%
ketamine conference
NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 28, 2024
Published: 2024-03-21 (Crawled : 20:00) - prnewswire.com
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 2.95%
H: 15.38%
C: 7.69%
report year update pharmaceuticals financial results
NRx Pharmaceuticals Announces Results of the Vote Held During the Special Meeting of Shareholders
Published: 2024-03-21 (Crawled : 18:00) - prnewswire.com
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 1.03%
H: 7.76%
C: 3.08%
pharmaceuticals meeting results
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Plan to Distribute Shares of HOPE Therapeutics and Royalty Rights on Ketamine Sales to Existing NRx Shareholders
Published: 2024-03-18 (Crawled : 12:30) - prnewswire.com
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 2.5%
H: 22.19%
C: 10.4%
sales ketamine hope pharmaceuticals royalty therapeutics
NRx Pharmaceuticals (NASDAQ:NRXP) Completes Memorandum of Understanding and Collaborations with Distribution Partners for HTX-100 (IV Ketamine)
Published: 2024-03-11 (Crawled : 12:30) - prnewswire.com
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 4.34%
H: 12.5%
C: 4.53%
htx-100 distribution pharmaceuticals
NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient, Last Visit in its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
Published: 2024-03-04 (Crawled : 13:30) - prnewswire.com
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: -1.85%
H: 27.88%
C: 20.93%
nrx-101 depression treatment pharmaceuticals trial
NRx Pharmaceuticals Announces Definitive Purchase Agreement for Common, Unregistered Shares at $0.38 per Share
Published: 2024-03-01 (Crawled : 13:30) - prnewswire.com
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 3.06%
H: 20.11%
C: 18.41%
pharmaceuticals agreement
NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million Underwritten Public Offering of Common Stock Together with investor Commitment for Additional $1 million
Published: 2024-02-27 (Crawled : 14:30) - biospace.com/
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: -31.5%
H: 5.02%
C: 0.38%
million offering
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
Published: 2024-02-26 (Crawled : 21:00) - prnewswire.com
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: -31.5%
H: 5.02%
C: 0.38%
offering
NRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024
Published: 2024-02-26 (Crawled : 16:00) - biospace.com/
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 6.89%
H: 0.81%
C: -9.08%
ceo conference hope pharmaceuticals
NRx Pharmaceuticals (Nasdaq:NRXP) to Launch HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024
Published: 2024-02-20 (Crawled : 15:00) - biospace.com/
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: -0.45%
H: 5.36%
C: -4.01%
ceo conference hope pharmaceuticals
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance of $5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW)
Published: 2024-02-12 (Crawled : 00:00) - prnewswire.com
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 3.52%
H: 5.64%
C: -9.43%
million payment milestone
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical Co. Ltd. (1975.TW) in Recent Financial Report
Published: 2024-02-09 (Crawled : 13:30) - prnewswire.com
NRXP 1 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 4.31%
H: 9.48%
C: 5.79%
report financial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.